|
|
|
|
Drug-Eluting Balloons May Breath New Life into NonStent Angioplasty
First balloons are approved in Europe, trial data shows excellent outcomes for PAD, restenosis.Cryoplasty Helps Prevent Restenosis The goal of using paclitaxel-coated balloons is to prevent restenosis, but an alternative to drugs...
|
|
|
Drug-Eluting Balloons May Breath New Life into Non-Stent Angioplasty
First balloons are approved in Europe, trial data shows excellent outcomes for PAD, restenosis.Cryoplasty Helps Prevent Restenosis The goal of using paclitaxel-coated balloons is to prevent restenosis, but an alternative to drugs...
|
|
|
Pioglitazone May Lower TLR, Restenosis After BMS Implantation
The diabetes drug pioglitazone reduces the need for target lesion revascularization (TLR) and appears to suppress in-stent neointimal proliferation following percutaneous coronary intervention (PCI) with bare-metal stent (BMS) implantation,...
|
|
|
Incorrect Wording in: Atherosclerotic Plaque Composition and Occurrence of Restenosis After Carotid Endarterec
_ Incorrect Wording in: Atherosclerotic Plaque Composition and Occurrence of Restenosis After Carotid Endarterec.
|
|
|
Long-term clinical efficacy of cutting balloon angioplasty followed by bare metal stent implantation for treat
DES group vs CBA + BMS group similar rates at 6-8 mo angiographic follow-up: Restenosis (10.3% vs 17.9%) Target lesion revascularization (TLR) (5.88% vs 10%) Major adverse cardiac events (MACE) (7.Long-term clinical efficacy of...
|
|
|
More Restenosis Following PCI in Diabetics With Certain Stents
_ More Restenosis Following PCI in Diabetics With Certain Stents.
|
|
|
More Restenosis Following PCI in Diabetics With Certain Stents
_ More Restenosis Following PCI in Diabetics With Certain Stents.
|
|
|
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAX
- (NewsRx.com) -- Boston Scientific Corporation (NYSE:BSX) today welcomed the publication of an article in the current edition of the Journal of American College of Cardiology (JACC) reviewing data on more than 19,000 patients from the...
|
|
|
Pervasis Therapeutics Presents Promising Preclinical Data for its Minimally Invasive Cell Therapy
In this preclinical study, researchers evaluated treatment with ultrasound-guided percutaneous (needle delivered) administration of PVS-10200 to the outside of porcine (pig) femoral arteries immediately following angioplasty and stent...
|
